Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanded Access Protocol to Provide Ficlatuzumab to P05538 Patient 0001-000412

NCT02090127 is registered in ClinicalTrials.gov with AVEO Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02090127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02090127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanded Access Protocol to Provide Ficlatuzumab to P05538 Patient 0001-000412
Lead sponsor
AVEO Pharmaceuticals, Inc.
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mullerian mixed tumor of ovary